Phoebe Crammond
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Phoebe Crammond has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Aayushma Lohani
Immunovirology and Pathogenesis Program, Kirby Institute, University of New South Wales, Sydney, Australia
1 shared publicationAnthony Delaney
Intensive Care Unit, Royal North Shore Hospital, Sydney, Australia
1 shared publication- Anthony Dominic Kelleher
The Kirby Institute, University of New South Wales, Sydney, Australia
1 shared publication - Balasubramanian Venkatesh
The George Institute for Global Health, Sydney, Australia
1 shared publication Calum Walsh
Doherty Applied Microbial Genomics, Department of Microbiology & Immunology, Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Australia
1 shared publication- Chansavath Phetsouphanh
The Kirby Institute, University of New South Wales, New South Wales, Australia
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Expanded proinflammatory CD4 T cells expressing toll like receptor 4 in trauma associated acute lung injury
Acute lung injury (ALI) is characterised by hypoxia and inflammation that derives from diverse aetiologies. Delineating the molecular pathogeneses may identify treatable subgroups and inform clinical trials. Using a multi-omics approach, we analysed trauma-associated ALI (n = 9), COVID-19 ALI (n = 11), ICU controls (n = 13) using scRNA-seq, serum cytokine profiling, and bronchoalveolar lavage (BAL) microbiome analysis. We identified a population of activated CD4+ T cells expressing Toll-like receptor 4 (TLR4) and downstream NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome complex, predominantly in trauma-associated ALI (23% of CD45+ Cells) compared to COVID-19 ALI (14%) and ICU controls (15%). Serum IL-1RA and IL-6 were upregulated in trauma ALI, along with TLR4-binding ligand hyaluronan. TLR4 expression on CD4+ T cells was confirmed by spectral cytometry. Lung microbiome analysis revealed distinct diversity in trauma-associated ALI compared to COVID-19 ALI. These findings highlight TLR4-mediated inflammation in trauma-associated ALI and suggest potential precision medicine approaches for ALI management.
- 25 September 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessExpanded proinflammatory CD4 T cells expressing toll like receptor 4 in trauma associated acute lung injury
Acute lung injury (ALI) is characterised by hypoxia and inflammation that derives from diverse aetiologies. Delineating the molecular pathogeneses may identify treatable subgroups and inform clinical trials. Using a multi-omics approach, we analysed trauma-associated ALI (n = 9), COVID-19 ALI (n = 11), ICU controls (n = 13) using scRNA-seq, serum cytokine profiling, and bronchoalveolar lavage (BAL) microbiome analysis. We identified a population of activated CD4+ T cells expressing Toll-like receptor 4 (TLR4) and downstream NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome complex, predominantly in trauma-associated ALI (23% of CD45+ Cells) compared to COVID-19 ALI (14%) and ICU controls (15%). Serum IL-1RA and IL-6 were upregulated in trauma ALI, along with TLR4-binding ligand hyaluronan. TLR4 expression on CD4+ T cells was confirmed by spectral cytometry. Lung microbiome analysis revealed distinct diversity in trauma-associated ALI compared to COVID-19 ALI. These findings highlight TLR4-mediated inflammation in trauma-associated ALI and suggest potential precision medicine approaches for ALI management.